Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Samonis

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG)C Kouroussis, E Xydakis, A Potamianou, et al.
British Journal of Cancer|March 2, 2006
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)J Souglakos, N Androulakis, K Syrigos, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II studyD Mavroudis, M Veslemes, Ch Kouroussis, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trialV Georgoulias, G Samonis, E Papadakis, et al.
British Journal of Cancer|August 16, 2006
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancerG P Stathopoulos, K Syrigos, G Aravantinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative GroupD Mavroudis, N Malamos, A Alexopoulos, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG)C Kouroussis, E Xydakis, A Potamianou, et al.
British Journal of Cancer|March 2, 2006
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)J Souglakos, N Androulakis, K Syrigos, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II studyD Mavroudis, M Veslemes, Ch Kouroussis, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2001
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trialV Georgoulias, G Samonis, E Papadakis, et al.
British Journal of Cancer|August 16, 2006
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancerG P Stathopoulos, K Syrigos, G Aravantinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative GroupD Mavroudis, N Malamos, A Alexopoulos, et al.
Pageof 14